Glucagon-like peptide-1 receptor agonist - Bristol-Myers SquibbAlternative Names: GLP-1 receptor agonist - Bristol-Myers Squibb
Latest Information Update: 21 Dec 2007
At a glance
- Originator Bristol-Myers Squibb
- Class Glucagon-like peptides
- Mechanism of Action Glucagon like peptide 1 receptor agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Type 2 diabetes mellitus